Literature DB >> 16144692

Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.

Håkan Axelson1, Erik Fredlund, Marie Ovenberger, Göran Landberg, Sven Påhlman.   

Abstract

Histopathological examination of solid tumors frequently reveals pronounced tumor cell heterogeneity with regards to cell organization, cell morphology, cell size, nuclei morphology, etc. Analyses of gene expression patterns by immunohistochemistry or in situ hybridization techniques further strengthen the actual presence of phenotypic heterogeneity, often demonstrating substantial diversity within a given tumor. The molecular mechanisms underlying the phenotypic heterogeneity are very complex with genetic, epigenetic and environmental components. Hypoxia, shortage in oxygen, greatly influences cellular phenotypes by altering the expression of specific genes, and is an important contributor to intra- and inter-tumor cell diversity as revealed by the pronounced but non-uniform expression of hypoxia-driven genes in solid tumors (reviewed in [Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-32; Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47.]). The oxygen pressure in solid tumors is generally lower than in the surrounding non-malignant tissues, and tumors exhibiting extensive hypoxia have been shown to be more aggressive than corresponding tumors that are better oxygenized [Vaupel P. Oxygen transport in tumors: characteristics and clinical implications. Adv Exp Med Biol 1996;388:341-51; Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 2001;18:243-59.]. We recently observed that hypoxic neuroblastoma cells and breast cancer cells lose their differentiated gene expression patterns and develop stem cell-like phenotypes [Jögi A, Øra I, Nilsson H, Lindeheim A, Makino Y, Poellinger L, et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 2002;99:7021-6; Helczynska K, Kronblad A, Jögi A, Nilsson E, Beckman S, Landberg G, et al. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 2003;63:1441-4.]. As low stage of differentiation in neuroblastoma and in breast cancer is linked to poor prognosis, hypoxia-induced dedifferentiation will not only contribute to tumor heterogeneity but could also be one mechanism behind increased aggressiveness of hypoxic tumors. The effect(s) of hypoxia on tumor cell differentiation status is the focus of this review.

Entities:  

Mesh:

Year:  2005        PMID: 16144692     DOI: 10.1016/j.semcdb.2005.03.007

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  102 in total

1.  Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.

Authors:  W M Harriss-Phillips; E Bezak; E K Yeoh
Journal:  Br J Radiol       Date:  2011-10       Impact factor: 3.039

2.  Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency.

Authors:  Julie Mathieu; Wenyu Zhou; Yalan Xing; Henrik Sperber; Amy Ferreccio; Zsuzsa Agoston; Kavitha T Kuppusamy; Randall T Moon; Hannele Ruohola-Baker
Journal:  Cell Stem Cell       Date:  2014-03-20       Impact factor: 24.633

3.  A hybrid model for three-dimensional simulations of sprouting angiogenesis.

Authors:  Florian Milde; Michael Bergdorf; Petros Koumoutsakos
Journal:  Biophys J       Date:  2008-06-27       Impact factor: 4.033

4.  The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency.

Authors:  Qingle Liang; Nana Bie; Tuying Yong; Ke Tang; Xiaolong Shi; Zhaohan Wei; Haibo Jia; Xiaoqiong Zhang; Haiyan Zhao; Wei Huang; Lu Gan; Bo Huang; Xiangliang Yang
Journal:  Nat Biomed Eng       Date:  2019-05-20       Impact factor: 25.671

5.  Marine Natural Products as Inhibitors of Hypoxic Signaling in Tumors.

Authors:  Dale G Nagle; Yu-Dong Zhou
Journal:  Phytochem Rev       Date:  2009-06       Impact factor: 5.374

6.  Hypoxia-inducible factor-1alpha suppressing apoptosis and increasing tolerance of lung cancer cells to chemotherapy.

Authors:  Wanguang Zhang; Huilan Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 7.  Three-dimensional context regulation of metastasis.

Authors:  Janine T Erler; Valerie M Weaver
Journal:  Clin Exp Metastasis       Date:  2008-09-24       Impact factor: 5.150

Review 8.  Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.

Authors:  Xiang-Qian Gu; Wei-Ping Zheng; Da-Hong Teng; Ji-San Sun; Hong Zheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

9.  Microcirculatory fraction (MCF(I)) as a potential imaging marker for tumor heterogeneity in breast cancer.

Authors:  Xiangyu Yang; Ewa Mrozek; Maryam Lustberg; Guang Jia; Steffen Sammet; Christina Sammet; Charles Shapiro; Michael V Knopp
Journal:  Magn Reson Imaging       Date:  2012-08-11       Impact factor: 2.546

Review 10.  Hypoxia-inducible factors in stem cells and cancer.

Authors:  Jolly Mazumdar; Vijay Dondeti; M Celeste Simon
Journal:  J Cell Mol Med       Date:  2009-11-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.